Diabetes risk among overweight and obese metabolically healthy young adults

Diabetes Care

Volumn 37, Issue 11, 2014, Pages 2989-2995

  Twig, Gilad ^a,b   Afek, Arnon ^c,d   Derazne, Estela ^b,c   Tzur, Dorit ^b   Cukierman Yaffe, Tali ^a,c   Gerstein, Hertzel C ^e   Tirosh, Amir ^a,f  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEDICAL CORPS   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d MINISTRY OF HEALTH   (Israel)

^e MCMASTER UNIVERSITY   (Canada)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; LEAN BODY WEIGHT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OBESITY; PHYSICAL ACTIVITY; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT; BLOOD; BLOOD PRESSURE; COMPLICATION; DIET RESTRICTION;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS; FASTING; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKOCYTE COUNT; MALE; OBESITY; OVERWEIGHT; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84910127342     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0869     Document Type: Article

References (29)

1. Appleton SL, Seaborn CJ, Visvanathan R, et al.; North West Adelaide Health Study Team. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013;36:2388-2394
2. Blüher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012;19:341-346
3. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912
4. Aung K, Lorenzo C, HinojosaMA, Haffner SM. Risk of developing diabetes and cardiovascular disease inmetabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab 2014;99:462-468
5. Arnlöv J, Sundström J, Ingelsson E, Lind L. Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men. Diabetes Care 2011;34:61-65
6. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011;34:210-215
7. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) 2012;20:651-659
8. Tirosh A, Shai I, Afek A, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med 2011;364:1315-1325
9. Tirosh A, Shai I, Tekes-Manova D, et al.; Israeli Diabetes Research Group. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005;353:1454-1462
10. Tirosh A, Afek A, Rudich A, et al. Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension 2010;56:203-209
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
12. Twig G, Afek A, Shamiss A, et al.White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care 2013;36:276-282
13. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 2013;159:758-769
14. Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506-E515
15. Arnlöv J, IngelssonE, SundströmJ, LindL.Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010;121:230-236
16. Hosseinpanah F, Barzin M, Sheikholeslami F, Azizi F. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol 2011;107:412-416
17. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012;97:2482-2488
18. Tirosh A, Shai I, Bitzur R, et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008;31:2032-2037
19. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51:455-461
20. Pecht T, Gutman-Tirosh A, Bashan N, Rudich A. Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans. Obes Rev 2014;15:322-337
21. Samocha-Bonet D, Campbell LV, Viardot A, et al. A family history of type 2 diabetes increases risk factors associated with overfeeding. Diabetologia 2010;53:1700-1708
22. Jenkins AB, Batterham M, Samocha-Bonet D, Tonks K, Greenfield JR, Campbell LV. Segregation of a latent high adiposity phenotype in families with a history of type 2 diabetes mellitus implicates rare obesity-susceptibility genetic variants with large effects in diabetes related obesity. PLoS ONE 2013;8:e70435
23. Koskinen J, Magnussen CG, Sabin MA, et al. Youth overweight and metabolic disturbances in predicting carotid intima-media thickness, type 2 diabetes, and metabolic syndrome in adulthood: the cardiovascular risk in Young Finns study. Diabetes Care 2014;37:1870-1877
24. Vassy JL, Hivert MF, Porneala B, et al. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63:2172-2182
25. Würtz P, Soininen P, Kangas AJ, et al. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 2013;36:648-655
26. Nguyen QM, Srinivasan SR, Xu JH, et al. Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study. Diabetes Care 2011;34:2603-2607
27. McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011;96: E1756-E1760
28. Heianza Y, Arase Y, Tsuji H, et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J Clin Endocrinol Metab 2014:jc20134427.
29. Keith SW, Fontaine KR, Pajewski NM, Mehta T, Allison DB. Use of self-reported height and weight biases the body mass index-mortality association. Int J Obes (Lond) 2011;35:401-408